
- This event has passed.
Leveraging Clinical Pharmacology to Optimize Drug Development for Nonalcoholic Steatohepatitis (NASH) and Cholestatic Liver Diseases
December 9, 2019 @ 9:00 am - 4:45 pm
Leveraging Clinical Pharmacology to Optimize Drug Development for Nonalcoholic Steatohepatitis (NASH) and Cholestatic Liver Diseases
December 9
Silver Spring, Maryland
Scott Siler will provided commentary on the presentations during “Session 4: Clinical Trial Design and Endpoint Selection: Clinical Pharmacology Approaches to Optimizing the Safety and Efficacy of Therapies for NASH and Cholestatic Liver Diseases” in addition to providing a very brief (5 min) presentation of how QSP modeling can help with optimizing clinical trial design.